Research and Development
Bittium continued to make significant investments to develop its own products and product platforms. In January–December 2020 the investments were EUR 22.8 million, representing 29.1 percent of the net sales.
The investments focused mainly on developing the tactical communication system and its products for defense industry, different kind of special terminal products for authorities and their related security software, as well as on developing medical technology products. The capitalized R&D investments are related to the investments in developing the software defined radio based tactical radios, Bittium Tough SRD™ product family, further development of tactical networks, secure smartphones and software, as well as to the investments in developing medical technology products.
| R&D investments, MEUR | 2020 12 months |
2019 12 months |
| Total R&D investments | 22.8 | 25.1 |
| Capitalized R&D investments | -13.6 | -15.6 |
| Depreciations and impairment of R&D investments | 6.1 | 3.1 |
| Cost impact on income statement | 15.4 | 12.6 |
| R&D investments, % of net sales | 29.1% | 33.4% |
| Capitalized R&D investments in balance sheet, MEUR | 2020 12 months |
2019 12 months |
| Balance sheet value in the beginning of the period | 39.1 | 26.6 |
| Additions during the period | 13.6 | 15.6 |
| Acquisitions of the business | ||
| Depreciations and impairment of R&D investments | -6.1 | -3.1 |
| Balance sheet value at the end of the period | 46.6 | 39.1 |